Value Sense
NEW
Stock Screener with Intrinsic Value
TRY FOR FREE
×
BNTX

BioNTech SE (BNTX)

Last Price$122.90.6%
Market Cap$29.5B
LTM ROIC - WACC
(48.4%)
5Y avg
14.6%
Biotechnology industry median
(127.8%)
Stock quality & Intrinsic value
6/10
0.3% undervalued
BNTX
is 33.5% undervalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

BioNTech SE ROIC - WACC

Annual
Quarterly
LTM
Industry median
Company stand-alone
BNTX
Healthcare
Crunching data... Almost there!
Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
ROIC - WACC
0.0%
(61.6%)
(38.0%)
(92.3%)
19.0%
146.8%
72.9%
(5.3%)
BNTX
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for BNTX and see if it's the right time to invest.
Dive in

BioNTech SE (BNTX) ROIC - WACC comparison analysis

Crunching data... Almost there!

BNTX key stats

USD
EUR
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
More ideas -->
Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms
Start for free ->

FAQ

1) What is BioNTech SE's ROIC - WACC?

As of today, Microsoft Corp's last 12-month ROIC - WACC is (48.4%), based on the financial report for Sep 30, 2024 (Q3 2024). The average annual ROIC - WACC for BioNTech SE have been 48.5% over the past three years, and 15.4% over the past five years.

2) Is BioNTech SE's ROIC - WACC Good?

As of today, BioNTech SE's ROIC - WACC is (48.4%), which is higher than industry median of (127.8%). It indicates that BioNTech SE's ROIC - WACC is Good.

3) How does BioNTech SE's ROIC - WACC compare to its peers?

As of today, BioNTech SE's ROIC - WACC is (48.4%), which is lower than peer median of (11.7%). The list of peers includes UTHR, NVO, REGN, GMAB, VRTX, INCY, ALNY, BGNE, MRNA, ARGX.